187 related articles for article (PubMed ID: 30664196)
1. Expression of flTF and asTF splice variants in various cell strains and tissues.
Pan L; Yu Y; Yu M; Yao S; Mu Q; Luo G; Xu N
Mol Med Rep; 2019 Mar; 19(3):2077-2086. PubMed ID: 30664196
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells.
Eisenreich A; Boltzen U; Malz R; Schultheiss HP; Rauch U
Circ J; 2011; 75(5):1235-42. PubMed ID: 21389637
[TBL] [Abstract][Full Text] [Related]
3. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.
Srinivasan R; Ozhegov E; van den Berg YW; Aronow BJ; Franco RS; Palascak MB; Fallon JT; Ruf W; Versteeg HH; Bogdanov VY
J Thromb Haemost; 2011 Oct; 9(10):2087-96. PubMed ID: 21812913
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues.
Wu M; Chen L; Xu T; Xu B; Jiang J; Wu C
Oncotarget; 2017 Aug; 8(32):53137-53145. PubMed ID: 28881799
[TBL] [Abstract][Full Text] [Related]
5. Splice variants of Tissue Factor and integrin-mediated signaling.
Srinivasan R; Bogdanov VY
Thromb Res; 2012 May; 129 Suppl 2():S34-7. PubMed ID: 22425320
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.
Eisenreich A; Zakrzewicz A; Huber K; Thierbach H; Pepke W; Goldin-Lang P; Schultheiss HP; Pries A; Rauch U
Oncol Rep; 2013 Jul; 30(1):462-70. PubMed ID: 23604472
[TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.
Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH
J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105
[TBL] [Abstract][Full Text] [Related]
8. Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.
Ünlü B; Bogdanov VY; Versteeg HH
Thromb Res; 2017 Aug; 156():1-7. PubMed ID: 28570958
[TBL] [Abstract][Full Text] [Related]
9. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.
Boltzen U; Eisenreich A; Antoniak S; Weithaeuser A; Fechner H; Poller W; Schultheiss HP; Mackman N; Rauch U
J Mol Cell Cardiol; 2012 May; 52(5):1056-65. PubMed ID: 22326437
[TBL] [Abstract][Full Text] [Related]
10. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?
van den Berg YW; Versteeg HH
Hamostaseologie; 2010 Aug; 30(3):144-9. PubMed ID: 20680231
[TBL] [Abstract][Full Text] [Related]
11. Alternatively spliced tissue factor induces angiogenesis through integrin ligation.
van den Berg YW; van den Hengel LG; Myers HR; Ayachi O; Jordanova E; Ruf W; Spek CA; Reitsma PH; Bogdanov VY; Versteeg HH
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19497-502. PubMed ID: 19875693
[TBL] [Abstract][Full Text] [Related]
12. Regulation and differential role of the tissue factor isoforms in cardiovascular biology.
Eisenreich A; Rauch U
Trends Cardiovasc Med; 2010 Aug; 20(6):199-203. PubMed ID: 22137642
[TBL] [Abstract][Full Text] [Related]
13. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.
Signaevsky M; Hobbs J; Doll J; Liu N; Soff GA
Semin Thromb Hemost; 2008 Mar; 34(2):161-9. PubMed ID: 18645921
[TBL] [Abstract][Full Text] [Related]
14. Tissue Factor: A Conventional or Alternative Target in Cancer Therapy.
Eisenreich A; Bolbrinker J; Leppert U
Clin Chem; 2016 Apr; 62(4):563-70. PubMed ID: 26896447
[TBL] [Abstract][Full Text] [Related]
15. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.
Kocatürk B; Van den Berg YW; Tieken C; Mieog JS; de Kruijf EM; Engels CC; van der Ent MA; Kuppen PJ; Van de Velde CJ; Ruf W; Reitsma PH; Osanto S; Liefers GJ; Bogdanov VY; Versteeg HH
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11517-22. PubMed ID: 23801760
[TBL] [Abstract][Full Text] [Related]
16. Alternatively spliced tissue factor is not sufficient for embryonic development.
Sluka SH; Akhmedov A; Vogel J; Unruh D; Bogdanov VY; Camici GG; Lüscher TF; Ruf W; Tanner FC
PLoS One; 2014; 9(5):e97793. PubMed ID: 24879059
[TBL] [Abstract][Full Text] [Related]
17. The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies.
Van Dreden P; Εlalamy Ι; Gerotziafas GT
Crit Rev Oncog; 2017; 22(3-4):219-248. PubMed ID: 29604900
[TBL] [Abstract][Full Text] [Related]
18. mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.
Lewis CS; Elnakat Thomas H; Orr-Asman MA; Green LC; Boody RE; Matiash K; Karve A; Hisada YM; Davis HW; Qi X; Mercer CA; Lucas FV; Aronow BJ; Mackman N; Versteeg HH; Bogdanov VY
J Thromb Haemost; 2019 Jan; 17(1):169-182. PubMed ID: 30472780
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells.
Chand HS; Ness SA; Kisiel W
Int J Cancer; 2006 Apr; 118(7):1713-20. PubMed ID: 16217771
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of murine alternatively spliced tissue factor.
Bogdanov VY; Kirk RI; Miller C; Hathcock JJ; Vele S; Gazdoiu M; Nemerson Y; Taubman MB
J Thromb Haemost; 2006 Jan; 4(1):158-67. PubMed ID: 16409465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
